| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $925K | — |
| R&D Expense | $60.9M | +37.2% |
| SG&A Expense | $22.6M | +102.1% |
| Operating Income | -$82.6M | -48.6% |
| Pre-tax Income | -$75.1M | -106.9% |
| Net Income | -$75.1M | -106.9% |
| EPS (Basic) | -$4.28 | — |
| EPS (Diluted) | -$4.28 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $136.6M | -7.8% |
| Short-term Investments | $175.8M | +259.2% |
| Current Assets | $315.9M | +57.7% |
| Total Assets | $335.7M | +50.8% |
| Current Liabilities | $15.2M | -34.0% |
| Total Liabilities | $25.4M | -30.6% |
| Stockholders' Equity | $310.4M | +66.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.6M | -37.3% |
| Capital Expenditures | $808K | +151.7% |
| Investing Cash Flow | -$125.3M | -588.6% |
| Financing Cash Flow | $184.1M | +99.0% |
| Free Cash Flow | -$71.4M | -38.0% |